Your browser doesn't support javascript.
loading
Negative regulation of urokinase receptor activity by a GPI-specific phospholipase C in breast cancer cells.
van Veen, Michiel; Matas-Rico, Elisa; van de Wetering, Koen; Leyton-Puig, Daniela; Kedziora, Katarzyna M; De Lorenzi, Valentina; Stijf-Bultsma, Yvette; van den Broek, Bram; Jalink, Kees; Sidenius, Nicolai; Perrakis, Anastassis; Moolenaar, Wouter H.
Afiliación
  • van Veen M; Division of Cell Biology, The Netherlands Cancer Institute, Amsterdam, Netherlands.
  • Matas-Rico E; Division of Cell Biology, The Netherlands Cancer Institute, Amsterdam, Netherlands.
  • van de Wetering K; Division of Molecular Oncology, The Netherlands Cancer Institute, Amsterdam, Netherlands.
  • Leyton-Puig D; Division of Cell Biology, The Netherlands Cancer Institute, Amsterdam, Netherlands.
  • Kedziora KM; Division of Cell Biology, The Netherlands Cancer Institute, Amsterdam, Netherlands.
  • De Lorenzi V; IFOM, The FIRC Institute of Molecular Oncology, Milan, Italy.
  • Stijf-Bultsma Y; Division of Biochemistry, The Netherlands Cancer Institute, Amsterdam, Netherlands.
  • van den Broek B; Division of Cell Biology, The Netherlands Cancer Institute, Amsterdam, Netherlands.
  • Jalink K; Division of Cell Biology, The Netherlands Cancer Institute, Amsterdam, Netherlands.
  • Sidenius N; IFOM, The FIRC Institute of Molecular Oncology, Milan, Italy.
  • Perrakis A; Division of Biochemistry, The Netherlands Cancer Institute, Amsterdam, Netherlands.
  • Moolenaar WH; Division of Cell Biology, The Netherlands Cancer Institute, Amsterdam, Netherlands.
Elife ; 62017 08 29.
Article en En | MEDLINE | ID: mdl-28849762
The urokinase receptor (uPAR) is a glycosylphosphatidylinositol (GPI)-anchored protein that promotes tissue remodeling, tumor cell adhesion, migration and invasion. uPAR mediates degradation of the extracellular matrix through protease recruitment and enhances cell adhesion, migration and signaling through vitronectin binding and interactions with integrins. Full-length uPAR is released from the cell surface, but the mechanism and significance of uPAR shedding remain obscure. Here we identify transmembrane glycerophosphodiesterase GDE3 as a GPI-specific phospholipase C that cleaves and releases uPAR with consequent loss of function, whereas its homologue GDE2 fails to attack uPAR. GDE3 overexpression depletes uPAR from distinct basolateral membrane domains in breast cancer cells, resulting in a less transformed phenotype, it slows tumor growth in a xenograft model and correlates with prolonged survival in patients. Our results establish GDE3 as a negative regulator of the uPAR signaling network and, furthermore, highlight GPI-anchor hydrolysis as a cell-intrinsic mechanism to alter cell behavior.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Regulación Neoplásica de la Expresión Génica / Transformación Celular Neoplásica / Hidrolasas Diéster Fosfóricas / Receptores del Activador de Plasminógeno Tipo Uroquinasa Límite: Animals / Female / Humans Idioma: En Revista: Elife Año: 2017 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Regulación Neoplásica de la Expresión Génica / Transformación Celular Neoplásica / Hidrolasas Diéster Fosfóricas / Receptores del Activador de Plasminógeno Tipo Uroquinasa Límite: Animals / Female / Humans Idioma: En Revista: Elife Año: 2017 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Reino Unido